翰思艾泰-B(03378)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

03378 翰思艾泰-B

休市中 02-06 16:08:02

16.100

-0.450

-2.72%

最高16.550	最低16.100	成交量7.46万
今开16.550	昨收16.550	日振幅2.72%
总市值21.93亿	流通市值21.93亿	总股本1.36亿
成交额122.96万	换手率0.05%	流通股本1.36亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"03378","market":"HK","secType":"STK","nameCN":"翰思艾泰-B","latestPrice":16.1,"timestamp":1770365282610,"preClose":16.55,"halted":0,"volume":74600,"delay":0,"changeRate":-0.027190332326283945,"floatShares":136218830,"shares":136218830,"eps":-0.918,"marketStatus":"休市中","change":-0.45,"latestTime":"02-06 16:08:02","open":16.55,"high":16.55,"low":16.1,"amount":1229607,"amplitude":0.02719,"askPrice":16.3,"askSize":1300,"bidPrice":16.1,"bidSize":2300,"shortable":0,"etf":0,"ttmEps":-1.222,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770600600000},"marketStatusCode":7,"adr":0,"listingDate":1766419200000,"exchange":"SEHK","adjPreClose":16.55,"openAndCloseTimeList":[[1770341400000,1770350400000],[1770354000000,1770364800000]],"volumeRatio":0.7663858639031862,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"000905","market":"SZ","secType":"STK","nameCN":"厦门港务","latestPrice":12.52,"timestamp":1770361200000,"preClose":13.16,"halted":0,"volume":43205900,"delay":0,"premium":"+14.05"}},"requestUrl":"/m/hq/s/03378","defaultTab":"news","newsList":[{"id":"1184892830","title":"翰思艾泰生物医药科技（03378）1月无新增发行 股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1184892830","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184892830?lang=zh_cn&edition=full","pubTime":"2026-02-05 16:43","pubTimestamp":1770281000,"startTime":"0","endTime":"0","summary":"翰思艾泰生物医药科技（武汉）股份有限公司于2026年2月5日发布2026年1月股份变动月报表。截至2026年1月31日，公司已发行股本总数为136,218,830股，注册股本为人民币13,621,883元，面值为每股人民币0.1元。本次报告期内未见新增发行、购回、注销或库藏股活动。公司表示，所有证券发行及其他事项均遵守相关上市规则及法律规定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"gpt_icon":0},{"id":"2608614323","title":"翰思艾泰-B(03378)：HX111完成首例病人用药","url":"https://stock-news.laohu8.com/highlight/detail?id=2608614323","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608614323?lang=zh_cn&edition=full","pubTime":"2026-02-04 20:51","pubTimestamp":1770209487,"startTime":"0","endTime":"0","summary":"智通财经APP讯，翰思艾泰-B 发布公告，公司已启动自主研发的候选药物HX111针对复发难治性淋巴瘤及实体瘤的Ⅰ期临床试验，已于近期顺利完成首例患者入组给药。HX111可高亲和、高特异性地结合肿瘤细胞表面的OX40分子，并能高效地经内吞作用进入肿瘤细胞后，由溶酶体蛋白酶裂解连接子，释放强效有效载荷，进而诱导肿瘤细胞凋亡。该领域目前仍处于早期探索阶段，HX111具备显著的先发优势，未来有望填补此类肿瘤治疗领域的空白。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1401744.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1173","03378","BK1535"],"gpt_icon":0},{"id":"2608436193","title":"翰思艾泰-B(03378)：肖婕妤由非执行董事获调任为执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2608436193","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608436193?lang=zh_cn&edition=full","pubTime":"2026-02-04 20:47","pubTimestamp":1770209223,"startTime":"0","endTime":"0","summary":"智通财经APP讯，翰思艾泰-B 发布公告，因工作调整，肖婕妤女士(肖女士)由非执行董事获调任为执行董事，自2026年2月8日起生效。于肖女士调任执行董事生效后，彼将不再担任审核委员会的成员，自2026年2月8日起生效。本公司已调任肖女士为其总部的主要联络人，负责维持与李先生的日常沟通。董事会进一步宣布，委任肖女士担任公司首席财务官、董事会秘书，自2026年2月8日起生效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1401739.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"翰思艾泰-B(03378)：肖婕妤由非执行董事获调任为执行董事","news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1535","BK1173","03378"],"gpt_icon":0},{"id":"2606759279","title":"翰思艾泰-B01月27日主力净流入17.3万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2606759279","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606759279?lang=zh_cn&edition=full","pubTime":"2026-01-27 16:15","pubTimestamp":1769501755,"startTime":"0","endTime":"0","summary":"01月27日, 翰思艾泰-B股价涨0.47%，报收17.05元，成交金额82.9万元，换手率0.04%，振幅2.30%，量比0.55。翰思艾泰-B今日主力资金净流入17.3万元，上一交易日主力净流出0万元。该股近5个交易日下跌1.16%，主力资金累计净流入34.2万元；近20日主力资金累计净流出429.6万元，其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127162304a6b22371&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127162304a6b22371&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03378","BK1173","BK1535"],"gpt_icon":0},{"id":"2606887262","title":"翰思艾泰-B：稳定价格期结束、无稳定价格行动及超额配股权失效","url":"https://stock-news.laohu8.com/highlight/detail?id=2606887262","media":"新浪港股","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606887262?lang=zh_cn&edition=full","pubTime":"2026-01-26 09:12","pubTimestamp":1769389920,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　翰思艾泰-B（03378）发布公告，有关全球发售的稳定价格期已于2026年1月17日（星期六）（即递交香港公开发售申请截止日期后第30日）结束。此外，保荐人兼整体协调人（为其本身及代表国际包销商）确认，国际发售项下发售股份并无超额分配。因此，超额配股权未获行使并已于2026年1月17日（星期六）失效。稳定价格操作人告知公司，稳定价格操作人或代其行事的任何人士于稳定价格期并无采取稳定价格行动。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-01-26/doc-inhiqsxi9274228.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1535","BK1173","03378"],"gpt_icon":0},{"id":"2605403681","title":"翰思艾泰-B(03378)：稳定价格期结束、无稳定价格行动及超额配股权失效","url":"https://stock-news.laohu8.com/highlight/detail?id=2605403681","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605403681?lang=zh_cn&edition=full","pubTime":"2026-01-23 21:53","pubTimestamp":1769176388,"startTime":"0","endTime":"0","summary":"智通财经APP讯，翰思艾泰-B(03378)发布公告，有关全球发售的稳定价格期已于2026年1月17日(星期六)(即递交香港公开发售申请截止日期后第30日)结束。此外，保荐人兼整体协调人(为其本身及代表国际包销商)确认，国际发售项下发售股份并无超额分配。因此，超额配股权未获行使并已于2026年1月17日(星期六)失效。稳定价格操作人告知公司，稳定价格操作人或代其行事的任何人士于稳定价格期并无采取稳定价格行动。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1396927.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1535","BK1173","03378"],"gpt_icon":0},{"id":"2604132633","title":"翰思艾泰-B01月19日获主力加仓42.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2604132633","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604132633?lang=zh_cn&edition=full","pubTime":"2026-01-19 16:15","pubTimestamp":1768810523,"startTime":"0","endTime":"0","summary":"01月19日, 翰思艾泰-B股价涨1.29%，报收17.28元，成交金额371.2万元，换手率0.16%，振幅3.22%，量比1.67。翰思艾泰-B今日主力资金净流入42.2万元，上一交易日主力净流入16.9万元。该股近5个交易日上涨1.95%，主力资金累计净流出38.2万元；近20日主力资金累计净流出463.8万元，其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119161736a72b8fc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119161736a72b8fc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1173","BK1535","03378"],"gpt_icon":0},{"id":"2603165921","title":"翰思艾泰重塑CD47赛道 引领肿瘤免疫治疗迈入黄金时代","url":"https://stock-news.laohu8.com/highlight/detail?id=2603165921","media":"泡财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603165921?lang=zh_cn&edition=full","pubTime":"2026-01-13 18:35","pubTimestamp":1768300517,"startTime":"0","endTime":"0","summary":"翰思艾泰以颠覆性创新打破困局，凭借两款重磅管线HX009、HX044的突破性进展，让CD47强势崛起，正式开启肿瘤免疫治疗的全新篇章。作为CD47新机制的开拓者与领航者，翰思艾泰跳出传统“别吃我”信号阻断的单一框架，深度解码CD47在肿瘤免疫中的核心调控密码。两款重磅管线不仅有效攻克了传统CD47疗法的毒性痛点，更开辟了免疫检查点联合靶向的全新治疗路径。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113190019a7158885&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113190019a7158885&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1173","BK1535","03378"],"gpt_icon":1},{"id":"2601193178","title":"厦门港务：拟61.78亿元购买集装箱码头集团70%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2601193178","media":"人民财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601193178?lang=zh_cn&edition=full","pubTime":"2026-01-06 18:43","pubTimestamp":1767696203,"startTime":"0","endTime":"0","summary":"人民财讯1月6日电，厦门港务(000905)1月6日公告，拟发行股份及支付现金购买厦门国际港务有限公司（简称“国际港务”）持有的厦门集装箱码头集团有限公司（简称“集装箱码头集团”）70%股权。交易价格为61.78亿元，其中现金对价9.27亿元，股份对价52.51亿元。同时，拟向不超过35名特定对象募集配套资金不超过35亿元，用于厦门港多式联运智慧物流中心项目、码头设备更新改造项目、翔安港区1#—5#集装箱泊位工程项目、支付本次交易现金对价、补充流动资金等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106185622a6fa1cb5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106185622a6fa1cb5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03378","BK1173","BK1535"],"gpt_icon":1},{"id":"2601193158","title":"翰思艾泰-B01月06日遭主力抛售51.0万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601193158","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601193158?lang=zh_cn&edition=full","pubTime":"2026-01-06 16:15","pubTimestamp":1767687352,"startTime":"0","endTime":"0","summary":"01月06日, 翰思艾泰-B股价跌0.12%，报收16.93元，成交金额333.5万元，换手率0.14%，振幅5.31%，量比0.22。翰思艾泰-B今日主力资金净流出51.0万元，上一交易日主力净流出50.6万元。该股近5个交易日上涨16.36%，主力资金累计净流出414.9万元；近20日主力资金累计净流出414.9万元，其中净流出天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106162108a6f9747e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106162108a6f9747e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03378","BK1173","BK1535"],"gpt_icon":0},{"id":"2601001547","title":"翰思艾泰-B01月05日主力净流出50.6万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2601001547","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601001547?lang=zh_cn&edition=full","pubTime":"2026-01-05 16:15","pubTimestamp":1767600945,"startTime":"0","endTime":"0","summary":"01月05日, 翰思艾泰-B股价跌0.64%，报收16.95元，成交金额614.5万元，换手率0.27%，振幅8.68%，量比0.30。翰思艾泰-B今日主力资金净流出50.6万元，上一交易日主力净流入6.0万元。该股近5个交易日下跌2.53%，主力资金累计净流出363.9万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流出363.9万元，其中净流出天数为3日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105162025a49e1693&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105162025a49e1693&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03378","BK1173","BK1535"],"gpt_icon":1},{"id":"2600105455","title":"翰思艾泰-B01月02日主力净流入6.0万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2600105455","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600105455?lang=zh_cn&edition=full","pubTime":"2026-01-02 16:15","pubTimestamp":1767341729,"startTime":"0","endTime":"0","summary":"01月02日, 翰思艾泰-B股价涨6.76%，报收17.06元，成交金额1226.2万元，换手率0.55%，振幅11.95%，量比0.21。翰思艾泰-B今日主力资金净流入6.0万元，上一交易日主力净流出97.4万元。该股近5个交易日下跌0.81%，主力资金累计净流出313.4万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流出313.4万元，其中净流出天数为2日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102161644a4942074&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102161644a4942074&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03378","BK1535","BK1173"],"gpt_icon":0},{"id":"2595223487","title":"翰思艾泰-B12月31日主力净流入112.7万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2595223487","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595223487?lang=zh_cn&edition=full","pubTime":"2025-12-31 16:15","pubTimestamp":1767168918,"startTime":"0","endTime":"0","summary":"12月31日, 翰思艾泰-B股价涨9.60%，报收15.98元，成交金额980.7万元，换手率0.47%，振幅13.92%，量比0.00。翰思艾泰-B今日主力资金净流入112.7万元，上一交易日主力净流出97.4万元。该股近5个交易日下跌50.06%，主力资金累计净流出206.6万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出206.6万元，其中净流出天数为2日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231161608a6e4b0fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231161608a6e4b0fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1173","03378","BK1535"],"gpt_icon":1},{"id":"2595886754","title":"厦门港务：购买厦门集装箱码头集团70%股权事项获深交所审核通过","url":"https://stock-news.laohu8.com/highlight/detail?id=2595886754","media":"财闻","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595886754?lang=zh_cn&edition=full","pubTime":"2025-12-30 08:58","pubTimestamp":1767056310,"startTime":"0","endTime":"0","summary":"12月30日，厦门港务早间公告，公司拟通过发行股份及支付现金的方式向厦门国际港务有限公司购买其持有的厦门集装箱码头集团有限公司70%股权，并向不超过35名符合条件的特定对象发行股份募集配套资金。深交所并购重组审核委员会于12月29日召开会议，对公司此次交易的申请进行了审议。本次交易尚需中国证券监督管理委员会同意注册后方可实施。本次交易最终能否完成注册，以及最终取得注册的时间均存在不确定性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230085912a487e850&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230085912a487e850&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1173","03378","BK1535"],"gpt_icon":0},{"id":"2595783331","title":"翰思艾泰-B12月29日主力净流出222.0万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2595783331","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595783331?lang=zh_cn&edition=full","pubTime":"2025-12-29 16:15","pubTimestamp":1766996158,"startTime":"0","endTime":"0","summary":"12月29日, 翰思艾泰-B股价跌16.33%，报收14.55元，成交金额2196.1万元，换手率1.04%，振幅17.08%，量比0.00。该股近5个交易日下跌54.63%，主力资金累计净流出222.0万元；近20日主力资金累计净流出222.0万元，其中净流出天数为1日。该股主力净额占比0.11%，港股市场排名2640/2703。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229162224a4853b54&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229162224a4853b54&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1535","BK1173","03378"],"gpt_icon":0},{"id":"2595420107","title":"港股异动 | 翰思艾泰-B(03378)跌超13% 较招股价已腰斩 总市值约20亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2595420107","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595420107?lang=zh_cn&edition=full","pubTime":"2025-12-29 13:50","pubTimestamp":1766987404,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，翰思艾泰-B跌超13%，盘中低见15.05港元再创新低，较招股价32港元已跌超50%。截至发稿，跌13.4%，报15.06港元，成交额1744.68万港元，总市值20.61亿港元。值得注意的是，翰思艾泰的管线均未实现商业化。财务方面，2023年、2024年及2025年前8个月，翰思艾泰期内亏损分别为8516.0万元、1.17亿元、8743.8万元。截至2025年10月31日，现金及其等价物为1.33亿元，流动负债总额为2.2亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1386423.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03378","BK1535","BK1173"],"gpt_icon":0},{"id":"1136212543","title":"异动解读 | 翰思艾泰-B盘中大跌13.11%，上市后持续承压，临床管线风险引担忧","url":"https://stock-news.laohu8.com/highlight/detail?id=1136212543","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136212543?lang=zh_cn&edition=full","pubTime":"2025-12-29 11:02","pubTimestamp":1766977346,"startTime":"0","endTime":"0","summary":"翰思艾泰-B今日盘中大跌13.11%，延续了其上市以来的疲软表现。消息面上，翰思艾泰-B自12月23日登陆港股以来表现不佳，上市首日即暴跌46.25%，市值缩水至约20亿元人民币。翰思艾泰-B的研发投入有限，却选择了CD47这一高难度靶点，而全球尚无同类药物成功获批。叠加公司短期内难以商业化的预期，市场对其长期价值持谨慎态度，导致股价持续承压。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["03378"],"gpt_icon":0},{"id":"2594266410","title":"厦门港务12月25日获融资买入1.35亿元，融资余额4.77亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2594266410","media":"新浪财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594266410?lang=zh_cn&edition=full","pubTime":"2025-12-26 12:48","pubTimestamp":1766724503,"startTime":"0","endTime":"0","summary":"两融数据显示，当日厦门港务获融资买入额1.35亿元，融资偿还1.25亿元，融资净买入930.79万元。截至12月25日，厦门港务融资融券余额合计4.79亿元。融资方面，厦门港务当日融资买入1.35亿元。截至9月30日，厦门港务股东户数4.18万，较上期减少20.04%；人均流通股17738股，较上期增加25.06%。分红方面，厦门港务A股上市后累计派现10.04亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251226125249a6d12b97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251226125249a6d12b97&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03378","BK1535","BK1173"],"gpt_icon":1},{"id":"2594263689","title":"185 万血汗钱一夜蒸发！血泪控诉！HSAT国配惨遭“ 大 V” 收割","url":"https://stock-news.laohu8.com/highlight/detail?id=2594263689","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594263689?lang=zh_cn&edition=full","pubTime":"2025-12-26 11:09","pubTimestamp":1766718540,"startTime":"0","endTime":"0","summary":"　　转发自路边社小作文$翰思艾泰-B$. 　　无良大 V 利用我对他的信任，短短 2 天我的血汗钱蒸发了 185 万。　　用我血与泪的教训告诉大家，不要参与任何与这个骗子大 V瞪羚社 Kris.Z 杨泽康有关的任何项目．。　　利用信任、大 V 身份以及信息不对等骗你入场，并要求 55 分账，给到翻倍预期；承诺给大V最低风险，带兄弟吃肉。　　利用多年好友的信任，以及“医药大 V”的身份、“上市翻倍”的预期，骗取我们参与这一场精心设计的骗局：","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/marketresearch/2025-12-26/doc-inheautu1243984.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["03378","BK1173","BK1535","SINA"],"gpt_icon":1},{"id":"2594284633","title":"翰思艾泰港交所上市首日大跌30%！5.9亿港元融资押注肿瘤免疫与ADC创新药，HX009领衔多管线布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2594284633","media":"摩熵医药","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594284633?lang=zh_cn&edition=full","pubTime":"2025-12-25 12:00","pubTimestamp":1766635251,"startTime":"0","endTime":"0","summary":"图源：摩熵医药数据库-全球药物研发数据库公司的定位是提供新一代肿瘤免疫治疗，如HX009、HX044及HX016，以对抗PD-1抗性；提供一流的ADC分子HX111，以精确治疗特定恶性肿瘤；以及提供新型自身免疫治疗，如BsAb双功能抗体HX035及HX038。2023年、2024年和2025年前八个月，翰思艾泰研发开支分别为人民币4,666.3万、7,472.1万和5,617.8万元；净亏损分别为人民币0.85亿、1.17亿和0.88亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225120125a475e3b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225120125a475e3b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06978","BK1574","03378","BK1173","BK1161","BK1535"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.hanxbio.com/","stockEarnings":[{"period":"1week","weight":-0.0501},{"period":"1month","weight":-0.0518},{"period":"3month","weight":-0.4969},{"period":"ytd","weight":0.0075}],"compareEarnings":[{"period":"1week","weight":-0.0302},{"period":"1month","weight":0.0038},{"period":"3month","weight":0.0121},{"period":"6month","weight":0.0684},{"period":"1year","weight":0.2713},{"period":"ytd","weight":0.0363}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"翰思艾泰生物医药科技（武汉）股份有限公司是一家主要从事肿瘤免疫疗法的研发的中国公司。该公司的产品管线有针对肿瘤学的临床阶段候选药物和临床前阶段候选药物，包括核心产品HX009及主要产品HX301及HX044，以及针对自身免疫和肿瘤市场的抗体偶联药物、双特异性抗体及单克隆抗体。HX009是一种自主研发的抗程序性细胞死亡蛋白1（PD-1）/信号调节蛋白α（SIRPα）双功能抗体融合蛋白。HX301是一种靶向集落刺激因子-1受体（CSF1R）、AMPK相关蛋白激酶5（ARK5）、FMS样酪氨酸激酶3（FLT-3）及细胞周期蛋白依赖性激酶4/6（CDK4/6）等关键通路的多靶点激酶抑制剂。HX044为一种新型双重功能抗细胞毒性T淋巴细胞相关蛋白4（CTLA-4）抗体SIRPα融合蛋白。","yearOnYearQuotes":[{"month":1,"riseRate":0.588235,"avgChangeRate":0.005427},{"month":2,"riseRate":0.411765,"avgChangeRate":0.008835},{"month":3,"riseRate":0.352941,"avgChangeRate":-0.021319},{"month":4,"riseRate":0.705882,"avgChangeRate":0.100651},{"month":5,"riseRate":0.352941,"avgChangeRate":0.046508},{"month":6,"riseRate":0.470588,"avgChangeRate":-0.00883},{"month":7,"riseRate":0.470588,"avgChangeRate":0.004276},{"month":8,"riseRate":0.470588,"avgChangeRate":-0.031033},{"month":9,"riseRate":0.588235,"avgChangeRate":-0.013577},{"month":10,"riseRate":0.75,"avgChangeRate":0.019136},{"month":11,"riseRate":0.625,"avgChangeRate":0.009468},{"month":12,"riseRate":0.625,"avgChangeRate":0.056179}],"exchange":"SEHK","name":"翰思艾泰-B","nameEN":"HANXBIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"翰思艾泰-B(03378)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供翰思艾泰-B(03378)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"翰思艾泰-B,03378,翰思艾泰-B股票,翰思艾泰-B股票老虎,翰思艾泰-B股票老虎国际,翰思艾泰-B行情,翰思艾泰-B股票行情,翰思艾泰-B股价,翰思艾泰-B股市,翰思艾泰-B股票价格,翰思艾泰-B股票交易,翰思艾泰-B股票购买,翰思艾泰-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"翰思艾泰-B(03378)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供翰思艾泰-B(03378)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}